Evidence map›Paper›PMID 36389283›Full record

ArticleCytotechnology2022

A feasibility study of different commercially available serum-free mediums to enhance lentivirus and adeno-associated virus production in HEK 293 suspension cells.

Gizem Celebi Torabfam, Abuzer Alp Yetisgin, Cem Erdem, Aziz Cayli, Ozlem Kutlu, Sibel Cetinel

Open access · greenAbstract read
In one paragraph

Article in Cytotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An optimizing lentiviral titer determination assay based on Raji cells.American journal of translational research · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gizem Celebi Torabfam *Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, 34956 Turkey.ORCID 0000-0002-4985-3632
Abuzer Alp Yetisgin *Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, 34956 Turkey.ORCID 0000-0002-4581-9111
Cem ErdemFloraBio Technology, Urla, 35430 İzmir Turkey.
Aziz CayliFloraBio Technology, Urla, 35430 İzmir Turkey.
Ozlem KutluSabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, 34956 Turkey.ORCID 0000-0002-3769-2536
Sibel CetinelSabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, 34956 Turkey.ORCID 0000-0003-0248-9447
Sabancı Üniversitesi · TRIzmir Institute of Technology · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lentivirus and adeno-associated viruses are invaluable tools for biotechnology applications due to their genetic material delivery abilities both in vitro and in vivo. However, their large-scale productions with Good Manufacturing Practices yield low efficiency when adherent and serum dependent HEK293 (Human Embryonic Kidney) cells are used as the host. To increase production efficiency, HEK293 cells are adapted to grow in suspension using commercially available and chemically defined serum-free mediums. Suspended cells can be transiently transfected for viral vector production; however, significant improvements are still needed to increase yield and thereby cost effectiveness. Here, we evaluated four most preferred commercially available mediums that are IVY, FreeStyle293, LV-MAX, and BalanCD HEK293 for the transient transfection feasibility of lentiviral (LV) and adeno-associated virus serotype 2 (AAV2) production in FlorabioHEK293 suspension cells. The highest transfection efficiency was over 90% and obtained by using polyethyleneimine (PEI) 25 K and by media adaptation in IVY without using any transfection enhancer. For the first time the feasibility of HEK293 cells, which were adapted to grow in suspension culture by Florabio and IVY media, were tested for virus production. This study demonstrates the best transfection medium for scalable and optimized production of Lentivirus and Adeno-Associated Virus in suspended HEK293 cell culture. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-022-00551-1.

Indexed as

AAV2LVSuspension cell cultureTransfection mediaVirus production

Identifiers

PMID36389283
PMCPMC9652196
OpenAlexW4307404606

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.